• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Phone App For Melanoma Screening to be Tested at MD Anderson

Article

DermoScan, created by an engineering faculty at the University of Houston, can help screen for melanoma. It has already been used to diagnose a dermal bacterial disease in Africa, in a NIH-sponsored study.

The idea sounds simple: Take a photo of a suspicious mole or lesion with your phone, run it through an embedded software program and find out within a few seconds if it is likely to be cancerous.

But it could make quick and inexpensive screening a reality for millions of people who lack access to medical specialists. A University of Houston professor created the

, called DermoScan, which is now being evaluated for further testing at the University of Texas MD Anderson Cancer Center. George Zouridakis, professor of

app

engineering technology

, has worked on the project since 2005, moving it to an application for a

after the iPhone became ubiquitous. The goal is to provide quick screening in rural areas or in the developing world, where specialty medical care generally isn't available, he said.

mobile phone

Early testing found the device to be accurate about 85 percent of the time, Zouridakis said, similar to the accuracy rate for dermatologists and more accurate than primary care physicians. Patients would be referred for follow-up if the lesion were suspected to be cancerous.

Read the original report here: http://bit.ly/1mCvYAx

Source: MedicalXpress

Related Videos
Will Shapiro
Mila Felder, MD, FACEP
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Dr Lucy Langer
Edward Arrowsmith, MD, MPH
Dr Kathi Mooney
Tiago Biachi de Castria, MD, PhD, Moffitt Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.